Publicaciones en colaboración con investigadores/as de Hospital Universitario San Cecilio (109)

2023

  1. Effectiveness and safety of integrase strand transfer inhibitors in Spain: a prospective real-world study

    Frontiers in Cellular and Infection Microbiology, Vol. 13

  2. Lung ultrasound score severity cut-off points in COVID-19 pneumonia. A systematic review and validating cohort

    Medicina Clinica, Vol. 160, Núm. 12, pp. 531-539

  3. Mpox Infection and Sexually Transmitted Infections: A Cross-Sectional Study from a Secondary Hospital in the May–September 2022 International Outbreak

    AIDS Research and Human Retroviruses, Vol. 39, Núm. 11, pp. 604-609

  4. Ruminococcus gnavus bacteremia: Literature review and a case report associated to acute flare of ulcerative colitis in an immunocompromised patient

    Anaerobe, Vol. 82

2022

  1. Acerca de la evaluación precoz mediante ecografía pulmonar de pacientes con disnea por COVID-19

    Emergencias : revista de la Sociedad Espanola de Medicina de Emergencias, Vol. 34, Núm. 4, pp. 327-328

  2. Characteristics of hepatitis C virus resistance in an international cohort after a decade of direct-acting antivirals

    JHEP Reports, Vol. 4, Núm. 5

  3. Erythema nodosum: An uncommon manifestation of Rickettsiosis

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 40, Núm. 3, pp. 151-152

  4. High efficacy of glecaprevir/pibrentasvir for HCV-infected individuals with active drug use

    Journal of Infection, Vol. 85, Núm. 3, pp. 322-326

  5. Identification of IL-6 Signalling Components as Predictors of Severity and Outcome in COVID-19

    Frontiers in Immunology, Vol. 13

2021

  1. Anakinra after treatment with corticosteroids alone or with tocilizumab in patients with severe COVID-19 pneumonia and moderate hyperinflammation. A retrospective cohort study

    Internal and Emergency Medicine, Vol. 16, Núm. 4, pp. 843-852

  2. Anakinra after treatment with corticosteroids alone or with tocilizumab in patients with severe COVID‑19 pneumonia and moderate hyperinflammation. A retrospective cohort study: reply

    Internal and Emergency Medicine

  3. Effects of Hepatitis C Virus (HCV) Eradication on Bone Mineral Density in Human Immunodeficiency Virus/HCV-Coinfected Patients

    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, Vol. 73, Núm. 7, pp. e2026-e2033

  4. Empirical treatment with doxycycline of fever of intermediate duration

    European Journal of Clinical Microbiology and Infectious Diseases

  5. Fatal sepsis months after bladder instillations with mycobacterium bovis in patient with sars-cov-2 infection

    Revista Espanola de Quimioterapia

  6. Glucocorticoids alone versus tocilizumab alone or glucocorticoids plus tocilizumab in patients with severe SARS-CoV-2 pneumonia and mild inflammation

    Medicina Clinica, Vol. 156, Núm. 12, pp. 602-605

  7. HIV/HBV coinfection: Temporal trends and patient characteristics, Spain, 2002 to 2018

    Eurosurveillance, Vol. 26, Núm. 25

  8. Hemophagocytic lymphohistiocytosis associated with Leishmania: A hidden passenger in endemic areas

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 39, Núm. 4, pp. 188-191

  9. Interleukin-1 and interleukin-6 inhibition in patients with COVID-19 and hyperinflammation

    The Lancet Rheumatology

  10. Progression to hepatitis C virus micro-elimination in people living with HIV in Spain

    Clinical Microbiology and Infection

2020

  1. Dalbavancin is a novel antimicrobial against Gram-positive pathogens: Clinical experience beyond labelled indications

    European Journal of Hospital Pharmacy, Vol. 27, Núm. 5, pp. 310-312